CD8A and neoplasm: Priming of anti-tumour CD8+ T cells by dendritic cells (DCs) occurs in the lymph node, a critical step in the cancer immunity cycle that is potentiated by anti-CTLA-4 immune checkpoint blockade (ICB) [20,21].